Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Liver inflammation during monocrotaline hepatotoxicity.

Bryan L Copple1, Patricia E Ganey, Robert A Roth

  • 1Institute for Environmental Toxicology, B-346 Life Sciences Building, Michigan State University, East Lansing, MI 48824, USA.

Toxicology
|August 21, 2003
PubMed
Summary

Monocrotaline (MCT) causes liver injury, with inflammation occurring after hepatocellular damage. Studies show neutrophils, Kupffer cells, and TNF-alpha are not critical mediators of this MCT hepatotoxicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dissociating hepatocellular necrosis from hepatic encephalopathy: a murine acetaminophen model to identify second-hit drivers of acute liver failure.

Toxicology mechanisms and methods·2026
Same author

Interleukin-10 disrupts liver repair in acetaminophen-induced acute liver failure.

Frontiers in immunology·2023
Same author

Good Cells Go Bad: Immune Dysregulation in the Transition from Acute Liver Injury to Liver Failure After Acetaminophen Overdose.

Drug metabolism and disposition: the biological fate of chemicals·2023
Same author

Pharmacokinetic and toxicodynamic concepts in idiosyncratic, drug-induced liver injury.

Expert opinion on drug metabolism & toxicology·2022
Same author

Key Characteristics of Human Hepatotoxicants as a Basis for Identification and Characterization of the Causes of Liver Toxicity.

Hepatology (Baltimore, Md.)·2021
Same author

Modulation of macrophage phenotype to treat liver fibrosis-Current approaches and future possibilities.

Advances in pharmacology (San Diego, Calif.)·2021

Area of Science:

  • Toxicology
  • Hepatology
  • Immunology

Background:

  • Monocrotaline (MCT), a pyrrolizidine alkaloid, causes significant hepatotoxicity in humans and animals.
  • Exposure commonly occurs through contaminated food and herbal products.
  • MCT induces time-dependent hepatic parenchymal cell (HPC) injury, inflammation, and coagulation system activation.

Purpose of the Study:

  • To investigate the role of inflammatory factors, specifically neutrophils (PMNs) and Kupffer cells, in MCT-induced hepatotoxicity.
  • To determine if tumor necrosis factor-alpha (TNF-alpha) is a critical mediator of MCT liver injury.
  • To elucidate the relationship between inflammation and hepatocellular damage following MCT exposure.

Main Methods:

  • Rats were administered Monocrotaline (MCT) intraperitoneally.

Related Experiment Videos

  • Neutrophil depletion was achieved using rabbit anti-PMN serum.
  • Kupffer cell function was inhibited using gadolinium chloride (GdCl(3)).
  • TNF-alpha synthesis was inhibited using pentoxifylline (PTX).
  • Hepatic parenchymal cell (HPC) injury, PMN accumulation, and coagulation activation were assessed.

    • Main Results:

    • MCT induced hepatocellular injury, neutrophil infiltration, and upregulation of neutrophil and monocyte chemokines.
    • Neutrophil depletion significantly reduced PMN accumulation but did not alter MCT-induced HPC injury.
    • Inhibition of Kupffer cells or TNF-alpha synthesis did not prevent MCT-induced liver injury.
    • Inflammation, including PMN accumulation, was found to be secondary to hepatocellular injury.

    Conclusions:

    • Neutrophils, Kupffer cells, and TNF-alpha are not critical mediators of Monocrotaline (MCT)-induced hepatotoxicity.
    • Inflammation observed after MCT treatment is likely a consequence, rather than a cause, of hepatocellular injury.
    • These findings suggest that therapeutic strategies targeting these inflammatory components may not be effective for MCT liver damage.